176 related articles for article (PubMed ID: 2867181)
1. Comparative pharmacokinetics of theophylline and ethylenediamine following single and repeated doses of a sustained-release aminophylline preparation to volunteers.
Cotgreave IA; Caldwell J
J Pharm Pharmacol; 1985 Sep; 37(9):618-21. PubMed ID: 2867181
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a sustained-release theophylline preparation in healthy subjects.
Goto M; Nakamoto Y; Sugiyama M; Yamashina H
J Pharmacobiodyn; 1983 Apr; 6(4):225-31. PubMed ID: 6620110
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
[TBL] [Abstract][Full Text] [Related]
5. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
[TBL] [Abstract][Full Text] [Related]
6. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
7. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
Goetz TE; Munsiff IJ; McKiernan BC
J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
[TBL] [Abstract][Full Text] [Related]
9. A multiple-dose study of sustained-release theophylline and aminophylline.
Meyer MC; Straughn AB; Lieberman P
Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
[TBL] [Abstract][Full Text] [Related]
10. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of sustained release theophylline in low and high multidose regimens.
Koëter GH; Jonkman JH; de Vries K; Schoenmaker R; Greving JE; de Zeeuw RA
Br J Clin Pharmacol; 1981 Nov; 12(5):647-51. PubMed ID: 7332728
[TBL] [Abstract][Full Text] [Related]
12. Theophylline levels in patients receiving a controlled-release aminophylline preparation (Phyllocontin Continus tablets).
Friend JA
J Int Med Res; 1979; 7 Suppl 1():67-9. PubMed ID: 437310
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of theophylline and aminophylline in man.
Aslaksen A; Bakke OM; Vigander T
Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of intravenous theophylline.
Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
[TBL] [Abstract][Full Text] [Related]
15. Theophylline and ethylenediamine pharmacokinetics following administration of aminophylline to septic patients with multiorgan failure.
Toft P; Heslet L; Hansen M; Klitgaard NA
Intensive Care Med; 1991; 17(8):465-8. PubMed ID: 1797890
[TBL] [Abstract][Full Text] [Related]
16. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
McKenzie S; Baillie E
J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
[TBL] [Abstract][Full Text] [Related]
17. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
Sansom LN; Milne RW; Cooper D
Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of theophylline and quinine in healthy volunteers following oral administration of a fixed drug combination.
Dieterich HA; Messer W; Jaehnchen E
Arzneimittelforschung; 1984; 34(4):520-2. PubMed ID: 6540112
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
20. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
